In a significant leap for minimally invasive surgical technology, Munich-based medtech innovator Symphera has successfully raised €2.4 million in a Seed financing round. This funding will propel the company’s groundbreaking work in automating tool-switching during laparoscopic procedures, effectively rendering manual instrument changes obsolete. With a simple push of a button, surgeons can seamlessly transition between…
AttoTude, a pioneering company in high-speed interconnect technology for artificial intelligence and hyperscale data center applications, has announced the successful closure of its $29 million Series A funding round. This latest investment follows an $11 million Seed Round concluded earlier this year. The Series A round saw contributions from notable investors, including Sutter Hill Ventures,…
In a landmark development for the field of regenerative medicine, Cellino Biotech, Inc. has been awarded up to $25 million in funding from the Advanced Research Projects Agency for Health (ARPA-H), a division within the U.S. Department of Health and Human Services. This grant will significantly advance Cellino’s NEBULA, a cutting-edge biomanufacturing technology designed to…
Illuma Labs, a pioneering force in voice authentication technology for banking institutions, has successfully closed a $9 million Series A funding round. The investment, led by LiveOak Ventures and supported by Forefront Venture Partners, Curql Fund, UsNet, Capital Factory, Connexus, and TDECU, will drive the company’s efforts to develop cutting-edge solutions to tackle fraud, voice…
Radiant Biotherapeutics, a cutting-edge biotechnology firm specializing in advanced antibody therapies, has announced the successful closure of a $35 million Series A financing round. This significant investment, spearheaded by the Bill & Melinda Gates Foundation and Amplitude Ventures, aims to further develop Radiant’s innovative Multabody™ platform, which is poised to revolutionize therapeutic approaches across various…
In a significant boost for the Life Sciences industry, Qualifyze has announced a landmark $54 million Series B funding round. This investment, led by global software investment firm Insight Partners, alongside existing backers HV Capital, HarbourVest Partners, H14, and Cherry Ventures, is set to propel Qualifyze into a new phase of growth and innovation. With…
In a landmark development for the quantum computing industry, Quantum Source has successfully closed a $50 million Series A funding round. The investment, spearheaded by Eclipse, was also supported by prominent investors including Standard Investments, Level VC, Canon Equity, as well as existing backers Pitango First, Grove Ventures, 10D, and Dell Technologies Capital. This latest…
LifeSpan Vision Ventures has made a significant investment in Remedium Bio, a biotechnology firm renowned for its groundbreaking gene therapy platform, Prometheus™. This latest funding is set to propel Remedium Bio’s innovative approach to gene therapy into new realms of clinical research and application. Remedium Bio is at the forefront of biotechnology with its Prometheus™…
webAI, an Austin-based leader in AI innovation, has announced a significant milestone in its mission to revolutionize artificial intelligence with the completion of a $60 million Series A funding round. This pivotal investment underscores the growing momentum behind webAI’s vision to democratize AI and enhance its accessibility for enterprises worldwide. The fresh capital injection brings…
Alosant, a trailblazer in customer experience technology for master-planned communities, proudly announces the completion of its Series A funding round, spearheaded by Greg Avis, co-founder and former Managing Director of Summit Partners. This pivotal development, combined with strategic leadership appointments, positions Alosant for significant growth and innovation in the proptech sector. Greg Avis, now Managing…
